Compare VYGR & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VYGR | MRT |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United States | Turkey |
| Employees | N/A | 473 |
| Industry | Biotechnology: Pharmaceutical Preparations | Rental/Leasing Companies |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 203.6M | 176.2M |
| IPO Year | 2015 | 2021 |
| Metric | VYGR | MRT |
|---|---|---|
| Price | $3.05 | $1.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $16.50 | $3.58 |
| AVG Volume (30 Days) | ★ 750.5K | 82.3K |
| Earning Date | 05-08-2026 | 08-08-2018 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,135,000.00 | N/A |
| Revenue This Year | $34.04 | $72.36 |
| Revenue Next Year | $7.92 | $95.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.88 | $1.12 |
| 52 Week High | $5.55 | $2.75 |
| Indicator | VYGR | MRT |
|---|---|---|
| Relative Strength Index (RSI) | 36.64 | 57.42 |
| Support Level | $2.96 | $1.55 |
| Resistance Level | $4.33 | $2.26 |
| Average True Range (ATR) | 0.18 | 0.12 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 10.71 | 73.76 |
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
Marti Technologies Inc is Turkiye's urban mobility platform, helping to solve the country's transportation needs through tech-enabled services powered by a single mobility super app. The Group aims to offer tech-enabled urban transportation services to consumers across Turkiye through three service offerings: ride-hailing, delivery, and two-wheeled electric vehicle services. The Group's ride-hailing service matches consumers with car, motorcycle, and taxi drivers. The Group's delivery service provides same-hour package delivery by leveraging the Group's existing network of car and motorcycle drivers and consumer base.